Press "Enter" to skip to content

New patent for Loxo Oncology drug VITRAKVI

0
Copyright © DrugPatentWatch. Originally published at New patent for Loxo Oncology drug VITRAKVI

Annual Drug Patent Expirations for VITRAKVI
Annual Drug Patent Expirations for VITRAKVI

Vitrakvi is a drug marketed by Loxo Oncology Inc and is included in two NDAs. It is available from one supplier.

The generic ingredient in VITRAKVI is larotrectinib. One supplier is listed for this compound. Additional details are available on the larotrectinib profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Loxo Oncology drug VITRAKVI
    Do NOT follow this link or you will be banned from the site!